In addition, the use of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors, which are frequently prescribed for these patients, was not associated with a higher risk of infection by the vírus.12 Corroborating these findings, Sabatino et al.22 observed in their cohort study that the pediatric age group had few cardiovascular comorbidities, leading to a mild clinical course of COVID, without mainly modifying mortality. Here, ACE is linked to infection.